NEW YORK (GenomeWeb) – Since 2012, the number of drugs on the market developed through personalized medicine approaches has increased by 62 percent, according to a new report issued by the Personalized Medicine Coalition today.
Get the full story This story is free
for registered users
Registering provides access to this and other free content.
Already have an account?